The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: WPP, William Hill Post Interim Revenue Growth

Fri, 09th Aug 2019 07:46

(Alliance News) - Stocks in London are set for a soft start on Friday, despite Wall Street's overnight rally, as investors are cautious ahead of the UK second-quarter GDP data release.In the UK, a flurry of data is released at 0930 BST. In addition to GDP, manufacturing and industrial production figures will be published alongside the UK trade balance.Ipek Ozkardeskaya, senior market analyst at London Capital Group, said a slowdown in growth in the UK would be no surprise to investors, nor to the Bank of England, which revised its 2019-20 growth forecasts significantly lower at its latest meeting due to increased no-deal Brexit risks."But a big miss in Britain's GDP data could trigger fresh headwinds in the pound and bring the possibility of a decline toward the 1.20 level against the US dollar back in perspective," said Ozkardeskaya.The pound was quoted at USD1.2140 early on Friday, broadly flat compared to USD1.2145 late Thursday.IG says futures indicate the FTSE 100 index of large-caps to open 22.1 points lower at 7,263.8 on Friday. The blue-chip index closed up 87.20 points, or 1.2%, at 7,285.90 on Thursday.In early UK company news, advertising firm WPP said its second-quarter results were slightly ahead of its internal expectations, with revenue rising by 2.3% to GBP4.03 billion.The company noted that an improvement in North America and the UK was partly offset by slower growth in Asia Pacific, Latin America, Africa & the Middle East and Central & Eastern Europe.For the six months to the end of June, WPP's revenue grew by 1.6% to GBP7.62 billion. Revenue on a constant currency basis was flat compared with last year, the difference to the reported number reflecting the weakening of the pound in the first half, primarily against the dollar and euro.Reported billings were down 0.5% at GBP26.53 billion, down 2.0% in constant currency. Estimated net new business billings of USD2.93 billion were won in the first half of the year, WPP said. Pretax profit dropped 44%, however, to GBP478.2 million, as general & administrative costs surged 28% to GBP552.8 million. "We are still in the early stages of our three-year turnaround plan, and we remain focused on returning the company to sustainable growth over that period. Our guidance for the full year is unchanged," said Chief Executive Mark Read.Building materials company CRH said it has completed the latest phase of its share buyback programme, returning a further EUR350 million of cash to shareholders. This brings total cash returned to shareholders of the Irish company under its ongoing share buyback programme to EUR1.35 billion since its commencement in May last year. CRH said it is considering further share buybacks, the details of which it will announce as part of its interim results release on August 22. Turning to London mid-caps, bookmaker William Hill posted a narrowed loss for the 26 weeks to July 2 of GBP63.5 million compared to GBP819.6 million a year earlier, as revenue rose 1.1% to GBP811.7 million from GBP802.9 million. A year ago, William Hill recorded an impairment charge of GBP882.8 million in the Retail segment following the announcement of the UK government's decision to reduce the maximum stake on fixed-odds betting terminals. William Hill said that in the first half there was a decline in Retail revenue of 12% after the implementation of GBP2 maximum stake on the gaming machines from April. In Online, William Hill reported growth of 14% during the period, primarily resulting from the acquisition of Mr Green in Sweden. There was also growth of 40% in William Hill US, driven by expansion in the country after the US Federal ban on sports betting was overturned by Supreme Court in May 2018."We are making good progress against the five-year strategy we outlined last year, delivering strong revenue growth in the US and other international markets and positioning William Hill well for future growth," said Chief Executive Philip Bowcock. Regus office owner IWG said it has entered into a second strategic partnership with TKP Corp. IWG will divest its Taiwanese operations to TKP, and the parties have agreed an exclusive master franchise agreement for the country.Service office provider said the deal follows the deal between IWG and TKP in April for the divestment of IWG's Japanese operations to TKP and related franchise agreement in respect of the Japan market.IWG will receive gross consideration of GBP22.7 million payable in cash at completion, which is expected to occur in September. Proceeds from the divestment will be used for IWG's general corporate purposes, it said.Hikma Pharmaceuticals said its pretax profit almost doubled in the first half of 2019 to USD226 million from USD141 million a year ago, as revenue rose to USD1.05 billion from USD979 million. "Our good half-year financial results demonstrate the breadth and resilience of our marketed portfolio, successful pipeline launches and actions we've taken to reduce costs and increase efficiencies," explained Chief Executive Siggi Olafsson.As a result, Hikma raised its annual guidance and said it now expects its Injectables revenue to be in the range of USD870 million to USD900 million and core operating margin to be in the range of 36% to 38%. Given the strong performance of the Generics business in the first half, Hikma said it now expects Generics revenue for the full year to be in the range of USD690 million to USD720 million.In the US on Thursday, Wall Street ended up the most in the past two months, with the Dow Jones Industrial Average ending up 1.4%, the S&P 500 up 1.9% and the Nasdaq Composite up 2.2%."The rally in the S&P 500 last night was enough to turn the index positive on the week, and that highlights how much sentiment has changed in the past couple of days. The sharp turnaround in US stocks coincided with a rebound in US government bond yields. It would appear that the latest battle in the trade war has come to an end," said CMC Markets UK's Madden.In Asia on Friday, the Japanese Nikkei 225 index ended up 0.4%. In China, the Shanghai Composite is down 0.7% and the Hang Seng index in Hong Kong is down 0.2%.Chinese factory price inflation fell below zero for the first time in three years, official data showed, the latest sign of weakening demand amid mounting trade tensions with the US.The producer price index - an important barometer of the industrial sector that measures the cost of goods at the factory gate - dropped 0.3% year-on-year in July, down from zero percent in June, according to the National Bureau of Statistics.A slowdown in factory gate inflation reflects sluggish demand, while a turn to deflation could dent corporate profits and drag on the world's number two economy, which in turn could lead to a drop in prices globally.The reading marks the first deflation since August 2016, and fell short of the minus 0.1% forecast in a Bloomberg News survey.In Europe, trade balance data are due from Germany at 0800 BST with French industrial output figures following at 0845 BST.

More News
24 May 2022 07:09

Hikma's Siggi Olafsson stands down as CEO

(Sharecast News) - Drugmaker Hikma Pharmaceuticals revealed on Tuesday that chief executive Siggi Olafsson has resigned from both the role and the company's board of directors in order to pursue other opportunities.

Read more
13 May 2022 16:01

UK shareholder meetings calendar - next 7 days

Monday 16 May 
88 Energy LtdAGM
Allianz Technology Trust PLCAGM
Blackbird PLCAGM
BSF Enterprise PLCGM
Crossword Cybersecurity PLCAGM
DigitalBox PLCAGM
Ethernity Networks LtdAGM
Jubilee Metals Group PLCGM - re right of directors to allot equity securities for cash
Mast Energy Developments PLCAGM
Metal Tiger PLCAGM
Tuesday 17 May 
Accesso Technology Group PLCAGM
Capital & Regional PLCAGM
Chaarat Gold Holdings LtdAGM
Chesnara PLCAGM
Equals Group PLCAGM
European Assets Trust PLCAGM
Fidelity Japan Trust PLCAGM
Fintel PLCAGM
Fresnillo PLCAGM
GCP Asset Backed Income Fund LtdAGM
GENinCode PLCFull Year Results
Greggs PLCAGM
IQGeo Group PLCAGM
Kefi Gold & Copper PLCGM re share placing
Mears Group PLCAGM
Mercantile Investment Trust PLCAGM
Vitec Group PLCAGM
Vivo Energy PLCAGM
Wednesday 18 May  
ABCAM PLCAGM
abrdn PLCAGM in Edinburgh
Alliance Pharma PLCAGM
Burford Capital LtdAGM
Coats Group PLCAGM
CVC Credit Partners European Opportunities LtdAGM
EKF Diagnostics Holdings PLCAGM
Highcroft Investments PLCAGM
Impax Environmental Markets PLCAGM
JPMorgan American Investment Trust PLCAGM
Keller Group PLCAGM
LMS Capital PLCAGM
Merchants Trust PLCAGM
PensionBee Group PLCAGM
Permanent TSB Group Holdings PLCAGM
PYX Resources LtdAGM
Riverstone Credit Opportunities Income PLCAGM
Schroder UK Public Private Trust PLCAGM
Science Group PLCAGM
Seplat Energy PLCAGM
TI Fluid Systems PLCAGM
Vesuvius PLCAGM
Thursday 19 May  
Bigblu Broadband PLCAGM
Brand Architekts Group PLCGM re takeover of InnovaDerma
Capital & Regional PLCAGM
Computacenter PLCAGM
Cornish Metals IncGM re equity raise
Dialight PLCAGM
Ebiquity PLCAGM
Eqtec PLCAGM
Essentra PLCAGM
Fevertree Drinks PLCAGM
Gamma Communications PLCAGM
Genuit Group PLCAGM
Headlam Group PLCAGM
Inchcape PLCAGM
InnovaDerma PLCGM re takeover by Brand Architekts
Irish Residential Properties REIT PLCAGM
K3 Business Technology Group PLCAGM
Light Science Tech Holdings PLCAGM
Live Co Group PLCGM
McColl's Retail Group PLCAGM
musicMagpie PLCAGM
Network International Holdings PLCAGM
Next PLCAGM
Pharos Energy PLCAGM
Property Franchise Group PLCAGM
Rotala PLCAGM
Smart Metering Systems PLCAGM
St James's Place PLCAGM
Tyman PLCAGM
Friday 20 May  
Bank of Cyprus Holdings PLCAGM
Croda International PLCAGM
Deliveroo PLCAGM
Georgia Capital PLCAGM
Hikma Pharmaceuticals PLCEGM re capital reduction
Keywords Studios PLCAGM
Real Estate Investors PLCAGM
Reckitt Benckiser Group PLCAGM
Resolute Mining LtdAGM
Restore PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
6 May 2022 09:47

LONDON BROKER RATINGS: Downgrades for Centrica and Rathbones

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
5 May 2022 12:11

LONDON MARKET MIDDAY: Pound slips as BoE opts for quarter-point hike

(Alliance News) - Stock prices in London were higher, while the pound was flat, on Thursday, after the Bank of England as expected raised UK interest rates by a quarter percentage point.

Read more
5 May 2022 10:51

Signs of slowdown on the continent

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

SIGNS OF SLOWDOWN ON THE CONTINENT (1051 GMT)

Read more
5 May 2022 09:24

TOP NEWS: Hikma shares fall 10% on delay to Jazz Pharmaceuticals drug

(Alliance News) - Shares in Hikma Pharmaceuticals PLC fell early Thursday, after the drugmaker downgraded guidance for its Generics business due to the delayed launch of a generic of the Xyrem treatment for narcolepsy.

Read more
5 May 2022 08:58

LONDON MARKET OPEN: Mondi and Shell lift FTSE 100 after strong updates

(Alliance News) - Stock prices in London opened sharply higher on Thursday after the US Federal reserve assuaged fears over further aggressive monetary policy tightening, while positive updates from Mondi and Shell boosted the FTSE 100.

Read more
5 May 2022 08:02

Hikma cuts 2022 generics guidance due to drug launch delay

(Sharecast News) - Hikma Pharmaceuticals cut guidance for its generics business on Thursday, citing a delay to a drug launch.

Read more
29 Apr 2022 17:44

IN BRIEF: Hikma says has not entered license agreement with Opiant

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Confirms that it has not entered into any transaction with Opiant Pharmaceutical UK, following a PR Newswire announcement issued on Friday. The release said Opiant and Hikma entered into a commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK.

Read more
29 Apr 2022 17:01

LONDON MARKET CLOSE: Stocks end volatile April on high note

(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while markets in the US sank as high-profile tech names disappointed.

Read more
29 Apr 2022 09:09

Hikma Pharmaceuticals notes "slow" start for Generics business in 2022

(Alliance News) - Hikma Pharmaceuticals PLC said on Friday that both its Injectables and Branded businesses have performed well at the start of the year but noted its Generics business has experienced some headwinds.

Read more
29 Apr 2022 08:32

Hikma shares fall as generics unit faces headwinds

(Sharecast News) - Hikma Pharmaceuticals shares fell as the company reported headwinds at its generics business.

Read more
29 Apr 2022 08:25

LONDON BRIEFING: Pearson has positive first quarter, buys language app

(Alliance News) - Educational materials publisher Pearson on Friday provided a positive update on first quarter trading, while also announcing a new acquisition.

Read more
21 Apr 2022 16:06

UK dividends calendar - next 7 days

Friday 22 April 
JPMorgan Global Emerging Markets Income Trust PLCdividend payment date
Henderson Eurotrust PLCdividend payment date
Monday 25 April 
abrdn Smaller Cos Income Trust PLCdividend payment date
Tuesday 26 April 
Anglo American PLCdividend payment date
Anglo American PLCspecial dividend payment date
Invesco Asia Trust PLCdividend payment date
Wednesday 27 April 
Close Brothers Group PLCdividend payment date
Thursday 28 April 
4imprint Group PLCex-dividend date
AEW UK REIT PLCex-dividend date
AVI Japan Opportunity Trust PLCex-dividend date
Bakkavor Group PLCex-dividend date
Carr's Group PLCex-dividend date
Coats Group PLCex-dividend date
CQS Natural Resources Growth & Income PLCex-dividend date
CQS New City High Yield Fund Ltdex-dividend date
Derwent London PLCex-dividend date
Drax Group PLCex-dividend date
Ecofin Global Utilities & Infrastructure Trust PLCex-dividend date
Fresnillo PLCex-dividend date
Henderson Far East Income Trust PLCex-dividend date
Hikma Pharmaceuticals PLCdividend payment date
HSBC Holdings PLCdividend payment date
Kenmare Resourcesex-dividend date
LSL Property Services PLCex-dividend date
M&G PLCdividend payment date
M P Evans Group PLCex-dividend date
Mobius Investment Trust PLCex-dividend date
Morgan Advanced Materials PLCex-dividend date
Morgan Sindall Group PLCex-dividend date
Mortgage Advice Bureau (Holdings) PLCex-dividend date
Northamber plcdividend payment date
Porvair PLCex-dividend date
Reckitt Benckiser Group PLCex-dividend date
Rightmove PLCex-dividend date
Sabre Insurance Group PLCex-dividend date
Sabre Insurance Group PLCspecial ex-dividend date
Schroder Oriental Income Fund Ltdex-dividend date
Secure Income REIT PLCex-dividend date
Smart Metering Systems PLCdividend payment date
St James's Place PLCex-dividend date
Synthomer PLCex-dividend date
Tate & Lyle PLCspecial ex-dividend date
TT Electronics PLCex-dividend date
Tyman PLCex-dividend date
XP Power Ltddividend payment date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
21 Apr 2022 14:37

IN BRIEF: Hikma Pharmaceuticals completes Custopharm deal

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Completes acquisition of Custopharm Inc from Water Street Healthcare Partners, following approval from the US Federal Trade Commission. Back in September, Hikma agreed to buy the California-based generic injectable products company for a total of up to USD425 million. Deal will add up to 13 approved products and additional pipeline products.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.